Can Apolipoprotein B (ApoB) miss part of your heart risk?
Yes—one analysis found that accounting for different blood particles changed risk-related rankings for 60% of people.
Researchers compared Apolipoprotein B (ApoB) with a calculated score in 1,861 adults. The group included many people with high Lipoprotein(a) — Lp(a), a cholesterol-carrying particle linked to heart risk. Everyone in the main analysis had fasting Triglycerides below 250 mg/dL.
The usual test helps count cholesterol-carrying particles in the blood. But those particles may not all carry the same risk. The calculated score gave more importance to types thought to cause more harm. It combined all three blood test results rather than treating every particle alike.
The average measured result was 89.9 mg/dL. The average calculated score was 103.7 mg/dL. Overall, 60% of people moved at least 10 points in their ranking within the group. Those shifts went in both directions.
The gap grew as levels of the extra-risk particle rose. At 300 nmol/L or higher, the calculated score was 1.91 times the measured result. This particle was the main reason the two measures differed.
A higher calculated score is not proof of more heart attacks. This analysis compared blood results and rankings, not future heart events. Its focus on people with elevated levels also limits broader conclusions.
For BioSocial members, the takeaway is about context, not replacing one number. Keeping these results together could make comparisons with community peers more useful. Similar particle counts may hide different mixes of particles.
What have your own blood results shown when you compare these measures side by side?

Comments
No comments yet.